Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/118298
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGergs, Ulrich-
dc.contributor.authorPham, Tu-Ha-
dc.contributor.authorRayo-Abella, Lina M.-
dc.contributor.authorHesse, Christin-
dc.contributor.authorGrundig, Peter-
dc.contributor.authorDhein, Stefan-
dc.contributor.authorHofmann, Britt-
dc.contributor.authorNeumann, Joachim-
dc.date.accessioned2025-02-24T10:27:43Z-
dc.date.available2025-02-24T10:27:43Z-
dc.date.issued2024-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/120257-
dc.identifier.urihttp://dx.doi.org/10.25673/118298-
dc.description.abstractDopamine receptors have been claimed not to directly increase contractility in the human heart. Therefore, we performed contraction experiments in isolated electrically driven human atrial preparations (HAP). For comparison, we performed contraction experiments with left atrial preparations of transgenic mice which harbor a cardiac overexpression of human D₁-dopamine receptors (D₁-TG). In D₁-TG, first we noted that dopamine (10 nM-10 µM cumulatively applied) in the presence of propranolol exerted a concentration- and time-dependent positive inotropic effect in D₁-TG. In a similar fashion, dopamine increased force of contraction in the presence of 0.4 µM propranolol in HAP and these effects were amplified by pre-treatment with inhibitor of phosphodiesterase III (1 µM) cilostamide. Moreover, contractile effects of dopamine in the presence of propranolol 0.4 µM in HAP were antagonized by odapipam, haloperidol, or raclopride. Ten micromolars of fenoldopam in the presence of cilostamide increased force of contraction in HAP and this effect was antagonized by SCH 23390. We conclude that stimulation of human D₁-dopamine receptors can increase force of contraction in the HAP.eng
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc615-
dc.titleContractile effects of stimulation of D₁-dopamine receptors in the isolated human atriumeng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleNaunyn-Schmiedeberg's archives of pharmacology-
local.bibliographicCitation.volume398-
local.bibliographicCitation.issue2-
local.bibliographicCitation.pagestart1497-
local.bibliographicCitation.pageend1508-
local.bibliographicCitation.publishernameSpringer-
local.bibliographicCitation.publisherplaceBerlin-
local.bibliographicCitation.doi10.1007/s00210-024-03340-z-
local.openaccesstrue-
dc.identifier.ppn1902514300-
cbs.publication.displayform2024-
local.bibliographicCitation.year2025-
cbs.sru.importDate2025-02-24T10:00:37Z-
local.bibliographicCitationEnthalten in Naunyn-Schmiedeberg's archives of pharmacology - Berlin : Springer, 1873-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
s00210-024-03340-z.pdf2.76 MBAdobe PDFThumbnail
View/Open